Specifically, various devices have been developed that positively select for EpCAM, a transmembrane glycoprotein expressed in epithelial tissues, cancer stem cells, inflammatory diseases and, most importantly, epithelial cancers [46,47,48]. The gene discussed is EPCAM; the disease is cancer.